Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 3376 KiB)
Fouquet, G.; Marié, C.; Collet, L.; Vilpoux, C.; Ouled-Haddou, H.; Nguyen-Khac, E.; Bayry, J.; Naassila, M.; Marcq, I.; Bouhlal, H. Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition. Cancers 2022, 14, 910. https://doi.org/10.3390/cancers14040910
Fouquet G, Marié C, Collet L, Vilpoux C, Ouled-Haddou H, Nguyen-Khac E, Bayry J, Naassila M, Marcq I, Bouhlal H. Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition. Cancers. 2022; 14(4):910. https://doi.org/10.3390/cancers14040910
Chicago/Turabian StyleFouquet, Grégory, Constance Marié, Louison Collet, Catherine Vilpoux, Hakim Ouled-Haddou, Eric Nguyen-Khac, Jagadeesh Bayry, Mickaël Naassila, Ingrid Marcq, and Hicham Bouhlal. 2022. "Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition" Cancers 14, no. 4: 910. https://doi.org/10.3390/cancers14040910